NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/29/2025
Back to search
Official data from USPTO
CDD
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
22
Latest update
04/03/2026
Trademark type
Combined
Nice classes
5, 41, 42, 44
Filing date
03/20/2024
Registration date
04/29/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/29/2025
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
3
Owner type
99
Owner location
Hong Kong, HK
Examiner
CHHINA, KARANENDRA S
Law office
M50
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the letters "CDD" in a stylized font, wrapped around the middle horizontally by two droplet-shaped figures that form a ring-like shape.
Holders and representatives
Holders
Centre for Chinese Herbal Medicine Drug Development Limited
Representatives
Sam Yip Idea Intellectual Limited
Technical classification
Nice Classes
Class 5Class 41Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for medical useoral preparation and topical preparation for gastrointestinal diseasescardiovascular diseasesautoimmune diseasecancer and rare muscle and heart diseases; Dietary supplements for medical use; Herbal preparations for medical purposes
Class 41
Educationclassescourses and seminars in the field of medicine and science; Providing of training in the field of clinical and scientific researchherbal medicinenew drug development; Organization and conducting of conferencescongressesseminars and workshops in the field of Chinese herbal medicine drug development; Publication of educational materials relating to traditional Chinese medicine and herbal medicine.
Class 42
Scientific research for medical purposes; Research and development in the field of traditional Chinese medicine; Scientific research in the nature of conducting clinical trials; Chemical research.
Class 44
Medical services; Consulting in the field of traditional Chinese medicine and Chinese herbal medicine; Health advisory services provided via the Internet.
Publications
History of USPTO decisions and trademark events.
22 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
04/29/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/11/2025
PUBO
PUBLISHED FOR OPPOSITION
03/11/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/05/2025
DMCC
DATA MODIFICATION COMPLETED
02/18/2025
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
02/13/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/05/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
02/05/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/05/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
02/05/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/05/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/04/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/04/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/04/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/29/2024
GNRT
NON-FINAL ACTION E-MAILED
09/29/2024
CNRT
NON-FINAL ACTION WRITTEN
09/29/2024
DOCK
ASSIGNED TO EXAMINER
09/27/2024
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
08/15/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/15/2024
NWAP
NEW APPLICATION ENTERED
03/20/2024
Continuous trademark protection
Get notified about every new filing that threatens CDD or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.